Praxis Precision Medicines announced that its investigational drug Elsunersen demonstrated good tolerability in clinical trials.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
After five months of sell-offs, is there finally a turning point? With expectations of a Democratic victory, funds bet on a rebound in clean energy stocks and options trading volume surges.
As prediction markets bet that Democrats will achieve a significant victory in Tuesday’s US midterm elections, traders are directing funds toward a group of stocks typically seen as beneficiaries under a left-leaning government, including clean energy shares.
China's AI features are here! Apple (AAPL.US) releases iOS 27.3 beta: introduces the Watch AI Listening Tool and a brand new Health App
Apple launched the first developer beta versions of iOS 27.3 and watchOS 27.3 on Tuesday.
Crypto prices
More
